Skip to main content
. 2024 Oct 25;45(1):33. doi: 10.1007/s10875-024-01821-7

Table 1.

Details of 45 dried blood spot samples from 43 patients with inborn errors of immunity analyzed in the current study

Patient Sample Age at sampling (months) Disease Causative Gene Causative Protein Mutation Protein levels encoded by the mutated gene (relative to ACTB)
Allele 1 Allele 2 Patient Healthy newborns Healthy adults
1 1 3 FHL type 3 UNC13D Munc13-4 c.1596 + 1G > C c.1255delC, p.Leu419Serfs*23 0.143 Mean, 10.9; SD, 2.6; Min, 5.9 Mean. 8.2; SD, 3.2; Min, 3.3
2 2 266 c.1596 + 1G > C c.1240C > T, p.Arg414Cys 0.192
3 3b 0 c.1596 + 1G > C c.118-308C > T 0.357
4 4b 0 c.1596 + 1G > C c.1545-2A > G 0.182
5 5 1 c.754-1G > C c.1596 + 1G > C 0.132
6b 0 0.120
6 7 4 c.1849-1G > C c.1849-1G > C 0.270
8b 0 0.360
7a 9 0 c.1596 + 1G > C c.1596 + 1G > C 0.280
8 10b 0 c.754-1G > C c.1596 + 1G > C 0.190
9 11 3 FHL type 5 STXBP2 Munc18-2 c.1197delC, p.Ala400Profs*18 c.1430C > T, p.Pro477Leu 1.120 Mean, 10.9; SD, 2.1; Min, 4.0 Mean, 7.8; SD, 2.1; Min, 4.8
10 12 1 FHL type 2 PRF1 perforin c.658G > A, p.Gly220Ser c.1090_1091delCT, p.Leu364Glufs*93 0.290 Mean, 0.33; SD, 0.28; Min, 0.28 Mean, 0.30; SD, 0.35; Min, 0.044
11 13 2 c.853_855delAAG, p.Lys285del c.1090_1091delCT, p.Leu364Glufs*93 0.330
12 14 9 HPS type 2 AP3B1 AP3B1 c.2546T > A, p.Leu849X c.1122_1123insAG, p.Phe375Serfs*11 0.183 Mean, 2.93; SD, 0.88; Min, 1.08 Mean, 0.91; SD, 0.25; Min, 0.58
13 15 102 c.364C > T, p.Arg122X c.2810-1G > T 1.080
14 16 38 c.2546T > A, p.Leu849X c.188T > A, p.Met63Lys 0.439
15 17 19 CGD CYBB p91-phox c.1528_1529delTT, p.Leu510Valfs*8 NA 0.010 Mean, 2.63; SD, 1.36; Min, 0.72 Mean, 0.78; SD, 0.51; Min, 0.30
16 18 318 c.121dupT, p.Tyr41Leufs*62 NA 0.020
17 19 87 c.1031C > T, p.Ser344Phe NA 0.010
18 20 62 c.252G > A, p.Ala84Ala NA 0.024
19 21 48 c.810G > A, p.Trp270X NA 0.015
20 22 105 c.271C > T, p.Arg91X NA 0.058
21 23 213 CGD CYBA p22-phox c.70G > A, p.Gly24Arg c.7C > T, p.Gln3X Below detection limit Mean, 7.1; SD, 4.1; Min, 1.9 Mean, 3.5; SD, 1.4; Min, 1.7
22 24 132 CGD NCF1 p47-phox c.75_76delGT, p.Tyr26Hisfs*26 c.75_76delGT, p.Tyr26Hisfs*26 0.010 Mean, 0.18; SD, 0.099; Min, 0.025 Mean, 0.10; SD, 0.062; Min, 0.057
23 25 12 WAS WAS WASP c.777 + 3_777 + 6delGAGT NA Below detection limit Mean, 0.098; SD, 0.039; Min, 0.022 Mean, 0.056; SD, 0.025; Min, 0.024
24 26 4 c.132 + 1G > T NA Below detection limit
25 27 70 c.982delC, p.Arg328Glyfs*117 NA 0.011
26 28 226 c.961C > T, p.Arg321X NA Below detection limit
27 29 6 c.1075C > A, p.Pro359Thr NA Below detection limit
28 30 26 XLA BTK BTK c.1574G > A, p.Arg525Gln NA 0.005 Mean, 0.60; SD, 0.16; Min, 0.25 Mean, 0.39; SD, 0.17; Min, 0.26
29 31 36 c.1856C > T, p.Pro619Leu NA 0.004
30 32 20 c.862C > T, p.Arg288Trp NA 0.017
31 33 386 c.1921C > T, p.Arg641Cys NA 0.029
32 34 113 c.902-904delAAG, p.Glu301del NA 0.055
33 35 456 c.95T > C, p.Leu32Ser NA 0.002
34 36 255 c.1856C > T, p.Pro619Leu NA 0.035
35 37 0 SCID ADA ADA1 c.218 + 2T > G c.218 + 2 T > G 0.040 Mean, 0.075; SD, 0.054; Min, 0.014 Mean, 0.18; SD, 0.096; Min, 0.047
36 38 3 c.218 + 2T > G c.632G > A, p.Arg211His 0.108
37 39 0 X-SCID IL2RG IL2Rγ c.865C > T, p.Arg289X NA Below detection limit NA NA
38 40 2 c.374A > G, p.Tyr125Cys NA Below detection limit
39 41b 0 CHS LYST LYST c.1673dupT, p.Leu558Phefs*22 c.5506C > T, p.Arg1836X 0.003 Mean, 0.056; SD, 0.035; Min, 0.01 Mean, 0.025; SD, 0.018; Min, 0.075
40 42 213 c.3393 + 1G > T c.3393 + 1G > T 0.016
41 43 373 c.5541_5542delAA, p.Arg1848Serfs*3 unknown 0.012
42 44 346 c.5541_5542delAA, p.Arg1848Serfs*3 unknown 0.009
43 45 346 c.5541_5542delAA, p.Arg1848Serfs*3 unknown 0.026

FHL familial hemophagocytic lymphohistiocytosis, HPS Hermansky-Pudlak syndrome, CGD chronic granulomatous disease, WAS Wiskott-Aldrich syndrome, XLA X-linked agammaglobulinemia, X-SCID X-linked SCID, CHS Chédiak-Higashi syndrome, NA not applicable

aFetal-onset case

bSamples were obtained from pateints before symptoms appeared and have been used for public screening of metabolic diseases